Watermark
  Back to Search Results

BGB-16673-107

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple-Ascending Doses of Tacabrutideg (BGB-16673) in Adults With Chronic Spontaneous Urticaria and in Healthy Participants

Request Information

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-16673-107

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT07005713

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 70 Years

Accepts Healthy Volunteers? No

No Study Documents

Locations

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 70 Years

Accepts Healthy Volunteers? No

No Study Documents